Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Neurodevelopmental Disorders 1Neoplasms 1Marijuana Abuse 1Epilepsy 1

Interventions

ziprasidone 1enzalutamide 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Surgical Procedures, Operative 1Spironolactone 1Sevelamer 1Rocuronium 1Registries 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Neuropsychological Tests 1Nafcillin 1Molindone 1Methylprednisolone 1Medical Marijuana 1Mass Screening 1Magnetoencephalography 1Lurasidone Hydrochloride 1Labetalol 1Histocompatibility Testing 1Haloperidol 1Fosfomycin 1Clozapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Epilepsy × Medical Marijuana × Clear all
NCT05863910 2023-11-30

CAN-RWE

University of Manitoba

Recruiting
500 enrolled

Marijuana Abuse, Epilepsy, Neoplasms, Neurodevelopmental Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡